SLU-PP-332 (5 mg) — Research Overview
SLU-PP-332 is an early-stage estrogen-related receptor (ERR) agonist studied in metabolic research in Canada. It is one of the newer compounds in the “exercise mimetic” research category.
Mechanism & Research Applications
SLU-PP-332 is investigated for activating the ERRα pathway, which is studied for increasing energy expenditure and fatty acid oxidation without physical activity. This mechanism is entirely distinct from GLP-1 and amylin compounds, offering researchers an alternative metabolic pathway to study.
As an emerging exercise-mimetic compound, SLU-PP-332 is of interest to laboratories studying metabolism and energy expenditure outside the incretin system.
Specifications
5 mg lyophilized powder per vial | ≥99% purity (HPLC-verified) | Batch-specific COA included
Quality & Sourcing in Canada
NuMe supplies SLU-PP-332 (5 mg) as part of its catalogue of weight loss peptides in Canada, research peptides in Canada, and buy peptides in Canada. Every batch is verified to ≥99% purity by HPLC, ships domestically from within Canada (typically 1–3 business days), and includes a batch-specific Certificate of Analysis. Free shipping applies to orders over $300 CAD.
Frequently Asked Questions
What is SLU-PP-332 studied for?
SLU-PP-332 is researched as an “exercise mimetic” — an ERR agonist studied for increasing energy expenditure and fat oxidation through a non-incretin pathway.
How is SLU-PP-332 different from GLP-1 compounds?
It works through the ERRα pathway rather than GLP-1 signalling, giving researchers an alternative mechanism to study for metabolic regulation.
Is SLU-PP-332 available in Canada?
Yes, shipped domestically with a batch COA verifying ≥99% purity. For research use only.
For Research Purposes Only. This product is intended exclusively for laboratory research and in-vitro testing. It is not for human or veterinary use, consumption, or any therapeutic application.
Reviews
There are no reviews yet.